Fern Halper, Ph.D., Appointed to GO2 for Lung Cancer Board of Directors
Brings background in data, AI, and analytics to help guide research collaboration and improved patient outcomes WASHINGTON, April 15, 2024 — GO2 for Lung Cancer (GO2) announced that the organization elected Fern Halper, Ph.D. to its board of directors. Halper is [...]